DRIO
DarioHealth Corp.
There isn't enough reported data to score DRIO yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
DRIO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Unavailable |
DRIO's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
DRIO PE Valuation
DRIO has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
DRIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect DRIO's losses to shrink, with revenue growing.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
DRIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$5.60 | +$33.20 |
| Q2 2024 | -$20.40 | +$21.40 |
| Q1 2024 | -$33.60 | +$11.40 |
| Q4 2023 | -$38.60 | +$12.20 |
DRIO has the stronger earnings trend. Trailing diluted EPS is down 114% for DRIO versus HIMS down 257%.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
DRIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.3M | +6.1% |
| Q2 2026 | $5.2M | -3.6% |
| Q1 2026 | $5.6M | -17% |
| Q4 2025 | $5.2M | -31% |
| Q3 2025 | $5M | -33% |
| Q2 2025 | $5.4M | -14% |
| Q1 2025 | $6.8M | +17% |
| Q4 2024 | $7.6M | +110% |
DRIO's revenue is recovering but still below its 2022 peak: $5M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -151% | +38 points |
| Q2 2026 | -125% | +46 points |
| Q1 2026 | -131% | +8.5 points |
| Q4 2025 | -164% | -10 points |
| Q3 2025 | -189% | -27 points |
| Q2 2025 | -171% | +88 points |
| Q1 2025 | -139% | +171 points |
| Q4 2024 | -153% | +240 points |
DRIO's operating margin was −151% last quarter, up 38 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over DRIO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over DRIO on profitability, with a higher operating margin.
DRIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.6M | +$1.8M |
| Q2 2026 | -$6.1M | -$46K |
| Q1 2026 | -$6.1M | +$648K |
| Q4 2025 | -$5.9M | +$840K |
| Q3 2025 | -$7.4M | -$2K |
| Q2 2025 | -$6.1M | +$5.3M |
| Q1 2025 | -$6.7M | +$6.5M |
| Q4 2024 | -$6.8M | +$671K |
DRIO has burned cash in almost every quarter: −$24M over the past year, against −$27M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over DRIO on cash generation, producing positive trailing cash flow while its opponent burns cash.
DRIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +29% | +2.7M shares |
| 1 year | +386% | +9.6M shares |
| 3 years | +756% | +10.7M shares |
| 5 years | +1620% | +11.4M shares |
DRIO has 12M diluted shares, up 386% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over DRIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
DRIO Net Leverage
DRIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
DRIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.8 | Oversold |
| Stochastic | 1.0 | Oversold |
DRIO's weekly RSI is 20 (oversold) and its Stochastic is 1 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
DRIO PE vs Healthcare Sector
DRIO has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
DRIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 62% below |
| 20 week MA | $6.07 | 73% below |
| 50 week MA | $8.02 | 79% below |
| 100 week MA | $10.7 | 85% below |
| 200 week MA | $28.9 | 94% below |
DRIO is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
DRIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $126.0 | $263.4 | +109% |
| 2021 | $263.4 | $273.0 | +3.6% |
| 2022 | $273.0 | $79.8 | -71% |
| 2023 | $79.8 | $34.4 | -57% |
| 2024 | $34.4 | $13.9 | -60% |
| 2025 | $13.9 | $10.0 | -28% |
| 2026 YTD | $10.0 | $1.65 | -84% |
DRIO has finished four years in a row lower, and it's down 84% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over DRIO on returns for 2026, with the stronger performance.